Clinical Information (ข้อมูลทางคลินิก):
GenomeHealth-Premium empowers you to take a proactive approach to health management through comprehensive genetic data from Whole Genome Sequencing (WGS), enabling the assessment of risks for major diseases.
It also provides a personalized DNA All Health report, guiding you to adjust your lifestyle and behaviors in alignment with your genetic profile, helping you take control of your health and achieve lasting well-being.
GenomeHealth-Premium is a comprehensive testing package that evaluates risks across four major disease groups, including cancer, cardiovascular diseases, Malignant Hyperthermia (a severe reaction to anesthesia), and additional findings related to other potential health conditions. The package also includes a personalized DNA All Health Report, offering in-depth analysis of nutrition, exercise, and lifestyle behaviors tailored to your genetic profile.
There are 5 reports included in the test.
1.Cancer screening report: analyze 92 genes and report for 18 cancer types includes Breast Cancer, Ovarian Cance, Uterine Cancer, Colorectal Cancer, Cutaneous melanoma, Gastric Cancer, Pancreatic Cancer, Prostate Cancer, Renal cell cancer, Thyroid Cancer, Sarcoma, Leukemia, Brain cancer, Lung cancer, Endocrine cancer, Neuroendocrine, Retinoblastoma and Other related syndromes
2.Cardio screening report: analyze 98 genes and report for 6 cardio conditions includes Aortopathy, Arrhythmias, Cardiomyopathies, Genetic forms of high blood pressure and high cholesterol, Hereditary Hemorrhagic Telangiectasia and Thrombophilia
3.Malignant hyperthermia report: Analyzes 3 genes related to Malignant Hyperthermia condition.
4.Additional findings report: Analyzes 16 genes and reports on 11 additional conditions related to inborn errors of metabolism and miscellaneous phenotypes
5.GenomeHealth SNP&Pick: Provides personalized recommendations on nutrition, exercise, and lifestyle adjustments tailored to your genetic profile, empowering you to live in harmony with your body.
Clinical Reference (เอกสารอ้างอิง):
1. https://www.omim.org (Retrieved 1 July 2022)
2.https://www.cancer.gov/publications/dictionaries/cancer-terms/def/inherited-cancer-syndrome ((Retrieved 1 July 2022)
3. Cirino AL, Harris S, Lakdawala NK, et al. Role of Genetic Testing in Inherited Cardiovascular Disease: A Review. JAMA Cardiol. 20172(10):1153-1160. doi:10.1001/jamacardio.2017.2352
4. Gonsalves, Stephen G., et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for the use of potent volatile anesthetic agents and succinylcholine in the context of RYR 1 or CACNA 1S genotypes. Clinical Pharmacology & Therapeutics 105.6 (2019): 1338-1344.